Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
585
currently held
Exits tracked
189
hand-checked
Sectors covered
1
across the portfolio
Countries covered
30
from every market
740 companies matching · Page 4 of 15
EOS (Ethical Oncology Science)
Principia Fund
ItalySector
Biotech
InvestorPrincipia SGR
Entry
2009
Hold
4yr
Exit
2013
Okairos
Boehringer Ingelheim Venture Fund
SwitzerlandSector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2011
Hold
2yr
Exit
2013
Corimmun
HTGF I
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2006
Hold
6yr
Exit
2012
BioVex
Ysios BioFund I
USSector
Biotech
InvestorYsios Capital Partners
Entry
2009
Hold
2yr
Exit
2011
KINAXO
HTGF I
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2006
Hold
5yr
Exit
2011
Jerini
VC Fonds Technologie Berlin
GermanySector
Biotech
InvestorIBB Ventures
Entry
2000
Hold
8yr
Owners
2
Exit
2008
evotec
Haspa BGM Evergreen
GermanySector
Biotech
InvestorHaspa Beteiligungsgesellschaft
Entry
1998
Hold
7yr
Exit
2005
sequenom
Haspa BGM Evergreen
United StatesSector
Biotech
InvestorHaspa Beteiligungsgesellschaft
Entry
1998
Hold
6yr
Exit
2004
Ciphergen Biosystems
Amadeus II Technology Fund
USSector
Biotech
InvestorAmadeus Capital Partners
Entry
2000
Hold
0yr
Exit
2000
Minoryx Therapeutics
Columbus Life Science Fund II
SpainSector
Biotech
InvestorColumbus Venture Partners
Entry
2015
Hold
11yr
Owners
4
Acousia Therapeutics
LBBW VC Evergreen Vehicle
GermanySector
Biotech
InvestorLBBW Venture Capital
Entry
2012
Hold
14yr
Owners
3
Adcendo
Jeito II
DenmarkSector
Biotech
InvestorJeito Capital
Entry
2021
Hold
5yr
Owners
3
Applyo Jena
Thueringer Zukunftsfonds III (TZF III)
GermanySector
Biotech
Investorbm-t Beteiligungsmanagement Thueringen
Entry
2024
Hold
2yr
Owners
3
CatalYm
Jeito I
GermanySector
Biotech
InvestorJeito Capital
Entry
2020
Hold
6yr
Owners
3
Cytospire Therapeutics
Abingworth Bioventures 8
UKSector
Biotech
InvestorAbingworth
Entry
2023
Hold
3yr
Owners
3
Dia Beta Labs
Co-Fund NI III
UKSector
Biotech
InvestorClarendon Fund Managers
Entry
2022
Hold
4yr
Owners
3
mbiomics
HTGF IV
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2023
Hold
3yr
Owners
3
Molecule
Backed Fund II
GermanySector
Biotech
InvestorBACKED VC
Entry
2020
Hold
6yr
Owners
3
Nuclera
CIC Fund II
UKSector
Biotech
InvestorCambridge Innovation Capital
Entry
2022
Hold
4yr
Owners
3
Sibylla Biotech
Claris Biotech I
ItalySector
Biotech
InvestorClaris Ventures SGR
Entry
2019
Hold
7yr
Owners
3
smartbax
Seedfonds Bayern
GermanySector
Biotech
InvestorBayern Kapital
Entry
2021
Hold
5yr
Owners
3
StimOxyGen
QUBIS Ltd
UKSector
Biotech
InvestorQubis
Entry
2025
Hold
1yr
Owners
3
Telum Therapeutics
Sodena Direct
SpainSector
Biotech
InvestorSodena
Entry
2020
Hold
6yr
Owners
3
Therini Bio
Apollo Health Ventures Fund II
United StatesSector
Biotech
InvestorApollo Health Ventures
Entry
2020
Hold
6yr
Owners
3
Trogenix
Old College Capital LP
UKSector
Biotech
InvestorOld College Capital
Entry
2023
Hold
3yr
Owners
3
ActiTrexx
HTGF III
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2021
Hold
5yr
Owners
2
Aerska
BlueYard Capital Fund III
UKSector
Biotech
InvestorBlueYard Capital
Entry
2025
Hold
1yr
Owners
2
ALKemist Bio
LIFTT
ItalySector
Biotech
InvestorLIFTT
Entry
2023
Hold
3yr
Owners
2
AMADIX
CRB Bio II
SpainSector
Biotech
InvestorCRB Health Tech
Entry
2011
Hold
15yr
Owners
2
AviadoBio
Dementia Discovery Fund
UKSector
Biotech
InvestorSV Health Managers
Entry
2020
Hold
6yr
Owners
2
Bloom Science
Apollo Health Ventures Fund II
United StatesSector
Biotech
InvestorApollo Health Ventures
Entry
2021
Hold
5yr
Owners
2
Carrick Therapeutics
Rosetta Capital V
UKSector
Biotech
InvestorRosetta Capital
Entry
2016
Hold
10yr
Owners
2
Cellvie
Oscar & Paul Venture Capital Fund I
SwitzerlandSector
Biotech
InvestorOscar & Paul (Beiersdorf Venture Capital)
Entry
2021
Hold
5yr
Owners
2
Cytosolix
Backed Fund III
USASector
Biotech
InvestorBACKED VC
Entry
2023
Hold
3yr
Owners
2
eGenesis
Wellington Partners Life Sciences
United StatesSector
Biotech
InvestorWellington Partners
Entry
2019
Hold
7yr
Owners
2
Entact Bio
Abingworth Bioventures 8
USSector
Biotech
InvestorAbingworth
Entry
2022
Hold
4yr
Owners
2
FundaMental Pharma
coparion
GermanySector
Biotech
Investorcoparion
Entry
2021
Hold
5yr
Owners
2
Gyala Therapeutics
Nara Health Capital
SpainSector
Biotech
InvestorNara Capital Partners
Entry
2020
Hold
6yr
Owners
2
HepaRegenix
Boehringer Ingelheim Venture Fund
GermanySector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2016
Hold
10yr
Owners
2
Infinite Roots
Atlantic Food Labs Fund I
GermanySector
Biotech
InvestorFoodLabs
Entry
2019
Hold
7yr
Owners
2
InnoUp Farma
Sodena Direct
SpainSector
Biotech
InvestorSodena
Entry
2015
Hold
11yr
Owners
2
Istesso
Parkwalk Opportunities EIS Fund
UKSector
Biotech
InvestorParkwalk Advisors
Entry
2017
Hold
9yr
Owners
2
Leon Nanodrugs
LBBW VC Evergreen Vehicle
GermanySector
Biotech
InvestorLBBW Venture Capital
Entry
2015
Hold
11yr
Owners
2
Medibiofarma
Sodena Direct
SpainSector
Biotech
InvestorSodena
Entry
2019
Hold
7yr
Owners
2
NanoSyrinx
BGF
UKSector
Biotech
InvestorBGF
Entry
2021
Hold
5yr
Owners
2
Numaferm
HTGF III
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2017
Hold
9yr
Owners
2
Page Therapeutics
XGEN Venture Life Sciences Fund
SwitzerlandSector
Biotech
InvestorXGen Venture SGR
Entry
2024
Hold
2yr
Owners
2
Palobiofarma
Sodena Direct
SpainSector
Biotech
InvestorSodena
Entry
2010
Hold
16yr
Owners
2
Pencil Biosciences
Northern Gritstone Evergreen
UKSector
Biotech
InvestorNorthern Gritstone
Entry
2023
Hold
3yr
Owners
2
Peptomyc
Alta Life Sciences Spain I FCR
SpainSector
Biotech
InvestorAlta Life Sciences
Entry
2016
Hold
10yr
Owners
2